ISSN: 2165-7904

Journal de thérapie contre l'obésité et la perte de poids

Accès libre

Notre groupe organise plus de 3 000 séries de conférences Événements chaque année aux États-Unis, en Europe et en Europe. Asie avec le soutien de 1 000 autres Sociétés scientifiques et publie plus de 700 Open Access Revues qui contiennent plus de 50 000 personnalités éminentes, des scientifiques réputés en tant que membres du comité de rédaction.

Les revues en libre accès gagnent plus de lecteurs et de citations
700 revues et 15 000 000 de lecteurs Chaque revue attire plus de 25 000 lecteurs

Indexé dans
  • Index Copernic
  • Google Scholar
  • Ouvrir la porte J
  • JournalSeek de génamique
  • Centre international pour l'agriculture et les biosciences (CABI)
  • Recherche de référence
  • Université Hamdard
  • EBSCO AZ
  • OCLC-WorldCat
  • Catalogue en ligne SWB
  • Texte intégral du CABI
  • Taxi direct
  • Publons
  • Fondation genevoise pour l'enseignement et la recherche médicale
  • Euro Pub
  • Université de Bristol
  • publié
  • ICMJE
Partager cette page

Abstrait

Emerging Role of the Fat Free Mass Preservation during Weight Loss Therapy through a Novel Advanced Bio-Impedance Device (BIA-ACC)

Nicoletta Canitano, Paola Paci and Flora Ippoliti

Topic: Psychological and stressful social situations, as well as factors of an unhealthy lifestyle (such as insufficient exercise, weight increase and/or social isolation) are potential causes of MUS (Medically Unexplained Symptoms) and obesity, usually overlooked by general practitioners. Obesity is often underestimated using BMI, since it does not reflect the real loss of fat mass after nutritional strategies. Scope: We analyzed the changes in fat mass (FM) and fat-free mass (FFM) in the presence of decreasing BMI, using a novel advanced bio-impedance device, BIA-ACC (Bioelectric Impedance Analyzer for Analisi Composizione Corporea) that measures numerous parameters of body composition. Methods: 109 patients were enrolled at the center for primary care for a routine check-up, all apparently free of disease but with problems of excess weight and MUS to varying degrees. The evaluation of the parameters BIA-ACC was performed at the first visit T0, and at follow-up T1, after about 2 months of a standard nutritional strategy. Results: BMI decreased in all patients. FFM, particularly skeletal muscle, was the 1st principal component (PCA1: 58%) that determines the well-being of the patients and a decrease of MUS. The 2nd component (PCA2: 22%) is the FM. We found 3 different patterns of patient response to BMI reduction: 75.23% showed loss of FM and minimally FFM; 17.43% showed loss of FM with preservation or increase FFM; 7.34% showed loss of FFM alone. Conclusions: Body composition analysis is a valuable non-invasive tool to monitor patients in the early stages of immune-metabolic dysregulation when clinical symptoms are not yet evident. Our results demonstrate the importance of the maintenance of FFM rather than the loss of FM alone during weight loss therapy. Preservation of skeletal muscle is essential to facilitate the stabilization of loss of only fat and thus to eliminate the MUS correlated to chronic stress.